Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Intangibles: 2015-2023

Historic Intangibles for Altimmune (ALT) over the last 7 years, with Sep 2023 value amounting to $12.4 million.

  • Altimmune's Intangibles changed negligibly% to $12.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $12.4 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $12.4 million for FY2022, which is 9.90% down from last year.
  • Latest data reveals that Altimmune reported Intangibles of $12.4 million as of Q3 2023, which was down 0.00% from $12.4 million recorded in Q2 2023.
  • In the past 5 years, Altimmune's Intangibles registered a high of $14.5 million during Q4 2019, and its lowest value of $12.4 million during Q1 2022.
  • Its 3-year average for Intangibles is $12.9 million, with a median of $12.4 million in 2023.
  • Per our database at Business Quant, Altimmune's Intangibles tumbled by 63.80% in 2019 and then rose by 1.69% in 2021.
  • Quarterly analysis of 5 years shows Altimmune's Intangibles stood at $14.5 million in 2019, then decreased by 5.96% to $13.6 million in 2020, then climbed by 1.43% to $13.8 million in 2021, then decreased by 9.90% to $12.4 million in 2022, then remained steady at $12.4 million in 2023.
  • Its last three reported values are $12.4 million in Q3 2023, $12.4 million for Q2 2023, and $12.4 million during Q1 2023.